SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Immunomedics (IMMU) - moderated
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
Recommended by:
bobbseytwins2001
CelebrityEquity
To: erickerickson who wrote (48055)12/11/2018 9:13:06 PM
From: ladyPI2 Recommendations  Read Replies (1) of 63284
 
I will add to my response about 483's - FDA has a site called ORA FOIA Reading Room. At FDA discretion, they proactively post 483's and responses and also post the ones that were requested under the Freedom of Info Act. The last post is dated 12/6/18. In 2018, there were 1,254 483's. I did search by company name and nothing comes up for immu, either as a 483 that FDA posted or that was requested per FOIA. You can also search for any written responses to 483's and nothing for immu. Of course, that begs the question, where did FDA News (or whatever that company was called that posted it) get it from???? Looks like an inside job.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News